Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
|
|
FEDERATED HERMES, INC. (FII)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/08/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 4.4% stake in ANNEXON, INC. |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 8.8% stake in FEDERATED HERMES, INC |
| 06/09/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 3.9% stake in MALLINCKRODT PLC |
| 06/09/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 16.7% stake in FUSION PHARMACEUTICALS, INC. |
| 05/10/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 9% stake in SERES THERAPEUTICS, INC. |
| 05/10/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 19.9% stake in REGULUS THERAPEUTICS, INC. |
| 03/10/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 4.6% stake in MERUS, N.V. |
| 03/10/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 4.7% stake in ARIS WATER SOLUTIONS, INC. |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.5% stake in Federated Hermes Inc. Class B |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 6.8% stake in XPONENTIAL FITNESS, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 10.8% stake in SHOTSPOTTER, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 14.5% stake in SERES THERAPEUTICS, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 20% stake in SCYNEXIS, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 11.2% stake in RHYTHM PHARMACEUTICALS, INC. |
| 02/01/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 17.2% stake in REGULUS THERAPEUTICS, INC. |
| 02/01/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 22.5% stake in MINERVA NEUROSCIENCES, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 8.5% stake in MERUS, N.V. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 6% stake in IDEAYA BIOSCIENCES, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 9.9% stake in DYNAVAX TECHNOLOGIES CORPORATION |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 6.6% stake in CASI PHARMACEUTICALS, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 18% stake in ATYR PHARMA, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 9.8% stake in ARIS WATER SOLUTIONS, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 16% stake in ARCTURUS THERAPEUTICS HOLDINGS, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 6.4% stake in ANNEXON, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 8.4% stake in ANAPTYSBIO, INC. |
| 02/01/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|